BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martin-Viñas JJ, Quigley EM. Immune response in irritable bowel syndrome: A systematic review of systemic and mucosal inflammatory mediators. J Dig Dis 2016;17:572-81. [PMID: 27426409 DOI: 10.1111/1751-2980.12379] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Turna J, Grosman Kaplan K, Patterson B, Bercik P, Anglin R, Soreni N, Van Ameringen M. Higher prevalence of irritable bowel syndrome and greater gastrointestinal symptoms in obsessive-compulsive disorder. Journal of Psychiatric Research 2019;118:1-6. [DOI: 10.1016/j.jpsychires.2019.08.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
2 Wang J, Wang Y, Zhou H, Gu W, Wang X, Yang J. Clinical efficacy and safety of ketotifen in treating irritable bowel syndrome with diarrhea. Eur J Gastroenterol Hepatol 2020;32:706-12. [PMID: 32317585 DOI: 10.1097/MEG.0000000000001737] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
3 Quigley EMM. Editorial: diet, inflammation and irritable bowel syndrome. Aliment Pharmacol Ther 2017;45:1278-9. [DOI: 10.1111/apt.14014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Zöller B, Ohlsson H, Waehrens R, Sundquist J, Sundquist K. Association of irritable bowel syndrome and venous thromboembolism. Scandinavian Journal of Gastroenterology 2018;53:784-9. [DOI: 10.1080/00365521.2018.1465118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
5 Midenfjord I, Polster A, Sjövall H, Törnblom H, Simrén M. Anxiety and depression in irritable bowel syndrome: Exploring the interaction with other symptoms and pathophysiology using multivariate analyses. Neurogastroenterology & Motility 2019;31. [DOI: 10.1111/nmo.13619] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
6 Mishima Y, Ishihara S. Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome. Int J Mol Sci. 2020;21. [PMID: 33212919 DOI: 10.3390/ijms21228664] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
7 Lazaridis N, Germanidis G. Current insights into the innate immune system dysfunction in irritable bowel syndrome. Ann Gastroenterol 2018;31:171-87. [PMID: 29507464 DOI: 10.20524/aog.2018.0229] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
8 El-Haggar SM, Hegazy SK, Abd-Elsalam SM, Bahaa MM. Pentoxifylline, a nonselective phosphodiesterase inhibitor, in adjunctive therapy in patients with irritable bowel syndrome treated with mebeverine. Biomed Pharmacother 2022;145:112399. [PMID: 34775240 DOI: 10.1016/j.biopha.2021.112399] [Reference Citation Analysis]
9 Kamp KJ, Han C, Shulman RJ, Cain KC, Barney P, Opp MR, Chang L, Burr RL, Heitkemper MM. Cytokine Levels and Symptoms Among Women with Irritable Bowel Syndrome: Considering the Role of Hormonal Contraceptive Use. Biol Res Nurs 2021;23:171-9. [PMID: 32677464 DOI: 10.1177/1099800420941252] [Reference Citation Analysis]
10 Viganò D, Zara F, Usai P. Irritable bowel syndrome and endometriosis: New insights for old diseases. Digestive and Liver Disease 2018;50:213-9. [DOI: 10.1016/j.dld.2017.12.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
11 Schepelmann M, Kupper N, Sladczyk M, Mansfield B, Manhardt T, Piatek K, Iamartino L, Riccardi D, Kariuki BM, Bassetto M, Kallay E. Stereo-Specific Modulation of the Extracellular Calcium-Sensing Receptor in Colon Cancer Cells. Int J Mol Sci 2021;22:10124. [PMID: 34576291 DOI: 10.3390/ijms221810124] [Reference Citation Analysis]
12 Smeriglio A, De Francesco C, Denaro M, Trombetta D. Prickly Pear Betalain-Rich Extracts as New Promising Strategy for Intestinal Inflammation: Plant Complex vs. Main Isolated Bioactive Compounds. Front Pharmacol 2021;12:722398. [PMID: 34594220 DOI: 10.3389/fphar.2021.722398] [Reference Citation Analysis]
13 Gajula P, Quigley EM. Overlapping irritable bowel syndrome and inflammatory bowel disease. Minerva Gastroenterol Dietol 2019;65:107-15. [PMID: 30746927 DOI: 10.23736/S1121-421X.19.02559-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ford AC, Moayyedi P, Chey WD, Harris LA, Lacy BE, Saito YA, Quigley EMM; ACG Task Force on Management of Irritable Bowel Syndrome. American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2018;113:1-18. [PMID: 29950604 DOI: 10.1038/s41395-018-0084-x] [Cited by in Crossref: 140] [Cited by in F6Publishing: 113] [Article Influence: 46.7] [Reference Citation Analysis]
15 Han CJ, Jarrett ME, Heitkemper MM. Relationships Between Abdominal Pain and Fatigue With Psychological Distress as a Mediator in Women With Irritable Bowel Syndrome. Gastroenterol Nurs 2020;43:28-39. [PMID: 31913959 DOI: 10.1097/SGA.0000000000000383] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Huang X, Oshima T, Tomita T, Fukui H, Miwa H. Butyrate Alleviates Cytokine-Induced Barrier Dysfunction by Modifying Claudin-2 Levels. Biology (Basel) 2021;10:205. [PMID: 33803334 DOI: 10.3390/biology10030205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kim YS, Kim N. Sex-Gender Differences in Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2018;24:544-558. [PMID: 30347934 DOI: 10.5056/jnm18082] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 12.3] [Reference Citation Analysis]
18 Alnoman A, Badeghiesh AM, Baghlaf HA, Dahan MH. Pregnancy, delivery, and neonatal outcomes among women with irritable bowel syndrome (IBS) an evaluation of over 9 million deliveries. J Matern Fetal Neonatal Med 2021;:1-8. [PMID: 33823718 DOI: 10.1080/14767058.2021.1903421] [Reference Citation Analysis]
19 İliaz R, Akyüz F, Yeğen G, Örmeci A, Göktürk S, Akyüz Ü, Baran B, Mutluay Ö, Evirgen S, Karaca Ç, Demir K, Beşışık F, Güllüoğlu M, Kaymakoğlu S. Does the number of mucosal immune cells differ in irritable bowel syndrome and its subtypes? Turk J Gastroenterol 2018;29:384-91. [PMID: 30249551 DOI: 10.5152/tjg.2018.17491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Weaver KR, Melkus GE, Fletcher J, Henderson WA. Serum Proteomics in African American Female Patients With Irritable Bowel Syndrome: An Exploratory Study. Nurs Res 2018;67:261-7. [PMID: 29698332 DOI: 10.1097/NNR.0000000000000281] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
21 Chong PP, Chin VK, Looi CY, Wong WF, Madhavan P, Yong VC. The Microbiome and Irritable Bowel Syndrome - A Review on the Pathophysiology, Current Research and Future Therapy. Front Microbiol. 2019;10:1136. [PMID: 31244784 DOI: 10.3389/fmicb.2019.01136] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 20.0] [Reference Citation Analysis]
22 Prospero L, Riezzo G, Linsalata M, Orlando A, D'Attoma B, Russo F. Psychological and Gastrointestinal Symptoms of Patients with Irritable Bowel Syndrome Undergoing a Low-FODMAP Diet: The Role of the Intestinal Barrier. Nutrients 2021;13:2469. [PMID: 34371976 DOI: 10.3390/nu13072469] [Reference Citation Analysis]
23 Rodríguez-Nogales A, Algieri F, Vezza T, Garrido-Mesa J, Molina-Tijeras JA, Rodríguez-Cabezas ME, Utrilla MP, Pischel I, Gálvez J. Calcium Pyruvate Exerts Beneficial Effects in an Experimental Model of Irritable Bowel Disease Induced by DCA in Rats. Nutrients 2019;11:E140. [PMID: 30634696 DOI: 10.3390/nu11010140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
24 Nilholm C, Larsson E, Sonestedt E, Roth B, Ohlsson B. Assessment of a 4-Week Starch- and Sucrose-Reduced Diet and Its Effects on Gastrointestinal Symptoms and Inflammatory Parameters among Patients with Irritable Bowel Syndrome. Nutrients 2021;13:416. [PMID: 33525489 DOI: 10.3390/nu13020416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
25 Vasant DH, Paine PA, Black CJ, Houghton LA, Everitt HA, Corsetti M, Agrawal A, Aziz I, Farmer AD, Eugenicos MP, Moss-Morris R, Yiannakou Y, Ford AC. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut 2021;70:1214-40. [PMID: 33903147 DOI: 10.1136/gutjnl-2021-324598] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
26 Nam Y, Min YS, Sohn UD. Recent advances in pharmacological research on the management of irritable bowel syndrome. Arch Pharm Res 2018;41:955-66. [PMID: 30132170 DOI: 10.1007/s12272-018-1068-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
27 Buhner S, Hahne H, Hartwig K, Li Q, Vignali S, Ostertag D, Meng C, Hörmannsperger G, Braak B, Pehl C, Frieling T, Barbara G, De Giorgio R, Demir IE, Ceyhan GO, Zeller F, Boeckxstaens G, Haller D, Kuster B, Schemann M. Protease signaling through protease activated receptor 1 mediate nerve activation by mucosal supernatants from irritable bowel syndrome but not from ulcerative colitis patients. PLoS One 2018;13:e0193943. [PMID: 29529042 DOI: 10.1371/journal.pone.0193943] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]